Molecular Pharmacology: 47 (2)

February 01, 1995; Volume 47,Issue 2

You have access
Novel properties of homomeric beta 1 gamma-aminobutyric acid type A receptors: actions of the anesthetics propofol and pentobarbital.
E Sanna, F Garau and R A Harris

Molecular Pharmacology February 1995, 47 (2) 213-217;
You have access
Multiple regions of G alpha 16 contribute to the specificity of activation by the C5a receptor.
C H Lee, A Katz and M I Simon

Molecular Pharmacology February 1995, 47 (2) 218-223;
You have access
Agonist-dependent phosphorylation of human muscarinic receptors in Spodoptera frugiperda insect cell membranes by G protein-coupled receptor kinases.
S K Debburman, P Kunapuli, J L Benovic and M M Hosey

Molecular Pharmacology February 1995, 47 (2) 224-233;
You have access
The class III antiarrhythmic drug amiodarone directly activates pertussis toxin-sensitive G proteins.
A Hagelüken, B Nürnberg, R Harhammer, L Grünbaum, W Schunack and R Seifert

Molecular Pharmacology February 1995, 47 (2) 234-240;
You have access
Welwitindolinone analogues that reverse P-glycoprotein-mediated multiple drug resistance.
C D Smith, J T Zilfou, K Stratmann, G M Patterson and R E Moore

Molecular Pharmacology February 1995, 47 (2) 241-247;
You have access
Activation of muscarinic cholinergic receptors blocks apoptosis of cultured cerebellar granule neurons.
G M Yan, S Z Lin, R P Irwin and S M Paul

Molecular Pharmacology February 1995, 47 (2) 248-257;
You have access
Differential regulation by anti-tumor-promoting 12-deoxyphorbol-13-phenylacetate reveals distinct roles of the classical and novel protein kinase C isozymes in biological responses of primary mouse keratinocytes.
Z Szallasi, K Kosa, C B Smith, A A Dlugosz, E K Williams, S H Yuspa and P M Blumberg

Molecular Pharmacology February 1995, 47 (2) 258-265;
You have access
Identification and characterization of endothelin receptors on rat osteoblastic osteosarcoma cells: down-regulation by 1,25-dihydroxy-vitamin D3.
P Nambi, H L Wu, D Lipshutz and U Prabhakar

Molecular Pharmacology February 1995, 47 (2) 266-271;
You have access
Differential in vivo induction of immediate early genes by oxotremorine in the central nervous system of long- and short-sleep mice.
L Tsiokas and M Watson

Molecular Pharmacology February 1995, 47 (2) 272-282;
You have access
Selective antagonist for the cerebellar granule cell-specific gamma-aminobutyric acid type A receptor.
E R Korpi, T Kuner, P H Seeburg and H Lüddens

Molecular Pharmacology February 1995, 47 (2) 283-289;
You have access
In vitro transcription termination by N,N'-bis(2-chloroethyl)-N-nitrosourea-induced DNA lesions.
R O Pieper, S L Noftz and L C Erickson

Molecular Pharmacology February 1995, 47 (2) 290-295;
You have access
Induction of cytochrome P4501A1 by aryl hydrocarbon receptor agonists in porcine aorta endothelial cells in culture and cytochrome P4501A1 activity in intact cells.
J J Stegeman, M E Hahn, R Weisbrod, B R Woodin, J S Joy, S Najibi and R A Cohen

Molecular Pharmacology February 1995, 47 (2) 296-306;
You have access
Characterization of two affinity states of adenosine A2a receptors with a new radioligand, 2-[2-(4-amino-3-[125I]iodophenyl)ethylamino]adenosine.
D R Luthin, R A Olsson, R D Thompson, D R Sawmiller and J Linden

Molecular Pharmacology February 1995, 47 (2) 307-313;
You have access
Molecular determinants of the species selectivity of neurokinin type 1 receptor antagonists.
L Pradier, E Habert-Ortoli, L Emile, J Le Guern, I Loquet, M D Bock, J Clot, L Mercken, V Fardin and C Garret

Molecular Pharmacology February 1995, 47 (2) 314-321;
You have access
Functional coupling of the beta 2-adrenoceptor to a pertussis toxin-sensitive G protein in cardiac myocytes.
R P Xiao, X Ji and E G Lakatta

Molecular Pharmacology February 1995, 47 (2) 322-329;
You have access
Characterization of cyclic nucleotide phosphodiesterases with cyclic GMP analogs: topology of the catalytic domains.
J Beltman, D E Becker, E Butt, G S Jensen, S D Rybalkin, B Jastorff and J A Beavo

Molecular Pharmacology February 1995, 47 (2) 330-339;
You have access
Characterization of cyclic nucleotide phosphodiesterases with cyclic AMP analogs: topology of the catalytic sites and comparison with other cyclic AMP-binding proteins.
E Butt, J Beltman, D E Becker, G S Jensen, S D Rybalkin, B Jastorff and J A Beavo

Molecular Pharmacology February 1995, 47 (2) 340-347;
You have access
Characterization of presynaptic calcium channels with omega-conotoxin MVIIC and omega-grammotoxin SIA: role for a resistant calcium channel type in neurosecretion.
T J Turner, R A Lampe and K Dunlap

Molecular Pharmacology February 1995, 47 (2) 348-353;
You have access
Selective actions of certain neuroactive pregnanediols at the gamma-aminobutyric acid type A receptor complex in rat brain.
L D McCauley, V Liu, J S Chen, J E Hawkinson, N C Lan and K W Gee

Molecular Pharmacology February 1995, 47 (2) 354-362;
You have access
Different subunit requirements for volatile and nonvolatile anesthetics at gamma-aminobutyric acid type A receptors.
B D Harris, G Wong, E J Moody and P Skolnick

Molecular Pharmacology February 1995, 47 (2) 363-367;
You have access
Mechanism of the dopamine-releasing actions of amphetamine and cocaine: plasmalemmal dopamine transporter versus vesicular monoamine transporter.
C Pifl, H Drobny, H Reither, O Hornykiewicz and E A Singer

Molecular Pharmacology February 1995, 47 (2) 368-373;
You have access
Identification of amino acids in the N-methyl-D-aspartate receptor NR1 subunit that contribute to the glycine binding site.
K A Wafford, M Kathoria, C J Bain, G Marshall, B Le Bourdellès, J A Kemp and P J Whiting

Molecular Pharmacology February 1995, 47 (2) 374-380;
You have access
Time- and voltage-dependent block of delayed rectifier potassium channels by docosahexaenoic acid.
J S Poling, J W Karanian, N Salem and S Vicini

Molecular Pharmacology February 1995, 47 (2) 381-390;
You have access
A human T lymphoid cell variant resistant to the acyclic nucleoside phosphonate 9-(2-phosphonylmethoxyethyl)adenine shows a unique combination of a phosphorylation defect and increased efflux of the agent.
B L Robbins, M C Connelly, D R Marshall, R V Srinivas and A Fridland

Molecular Pharmacology February 1995, 47 (2) 391-397;
You have access
Structure-activity relationships of new heterocycle-containing bisphosphonates as inhibitors of bone resorption and as inhibitors of growth of Dictyostelium discoideum amoebae.
M J Rogers, X Xiong, R J Brown, D J Watts, R G Russell, A V Bayless and F H Ebetino

Molecular Pharmacology February 1995, 47 (2) 398-402;
You have access
Mode of action of iron(III) chelators as antimalarials. III. Overadditive effects in the combined action of hydroxamate-based agents on in vitro growth of Plasmodium falciparum.
A Tsafack, J Golenser, J Libman, A Shanzer and Z I Cabantchik

Molecular Pharmacology February 1995, 47 (2) 403-409;
You have access
Oxidative metabolism of lansoprazole by human liver cytochromes P450.
L Pichard, R Curi-Pedrosa, C Bonfils, E Jacqz-Aigrain, J Domergue, H Joyeux, J Cosme, F P Guengerich and P Maurel

Molecular Pharmacology February 1995, 47 (2) 410-418;
You have access
Interaction of flavones and their bromoacetyl derivatives with NAD(P)H:quinone acceptor oxidoreductase.
S Chen, P S Deng, K Swiderek, M Li and S I Chan

Molecular Pharmacology February 1995, 47 (2) 419-424;

Main menu

User menu

Search

Table of Contents

In this issue

Navigate

More Information

ASPET's Other Journals